Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam J Prus

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 27, 2013
Acute, but not repeated, administration of the neurotensin NTS1 receptor agonist PD149163 decreases conditioned footshock-induced ultrasonic vocalizations in ratsAdam J Prus, Todd M Hillhouse, Amber L LaCrosse
Current Topics in Behavioral Neurosciences|April 12, 2018
Drug Discrimination: Historical Origins, Important Concepts, and PrinciplesJoseph H Porter, Adam J Prus, Donald A Overton
The Journal of Pharmacology and Experimental Therapeutics|June 4, 2009
Differential effects of M1 and 5-hydroxytryptamine1A receptors on atypical antipsychotic drug-induced dopamine efflux in the medial prefrontal cortexZhu Li, Adam J Prus, Jin Dai, et al.
Pharmacology, Biochemistry, and Behavior|May 30, 2026
Inhibition of compulsive behavior by dextromethorphan on schedule-induced polydipsia in rats: Role of NMDA, sigma-1, and 5-HT receptorsMadeline T Van Fossen, Alexia G Dalton, Adam J Prus
Drug Development Research|March 27, 2014
The discriminative stimulus effects of the neurotensin NTS1 receptor agonist PD149163 in rats: stimulus generalization testing with dopamine D1 and D2 receptor ligandsAdam J Prus, Candice J Schuck, Kristoffer R Rusch, et al.
Behavioural Pharmacology|February 24, 2006
Discriminative stimulus properties of the atypical antipsychotic drug clozapine in rats trained to discriminate 1.25 mg/kg clozapine vs. 5.0 mg/kg clozapine vs. vehicleAdam J Prus, Scott D Philibin, Alan L Pehrson, et al.
Brain Research|November 9, 2007
The neurotensin analog NT69L enhances medial prefrontal cortical dopamine and acetylcholine efflux: potentiation of risperidone-, but not haloperidol-, induced dopamine effluxAdam J Prus, Mei Huang, Zhu Li, et al.
Psychopharmacology|August 19, 2004
Discriminative stimulus properties of the atypical antipsychotic clozapine and the typical antipsychotic chlorpromazine in a three-choice drug discrimination procedure in ratsJoseph H Porter, Adam J Prus, Robert E Vann, et al.
Brain Research|January 17, 2017
Neurotensin NTS<sub>1</sub> and NTS<sub>2</sub> receptor agonists produce anxiolytic-like effects in the 22-kHz ultrasonic vocalization model in ratsFloyd F Steele, Shannon C Whitehouse, Jacob S Aday, et al.
Brain Research|January 9, 2007
5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampusZhu Li, Mei Huang, Adam J Prus, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 27, 2013
Acute, but not repeated, administration of the neurotensin NTS1 receptor agonist PD149163 decreases conditioned footshock-induced ultrasonic vocalizations in ratsAdam J Prus, Todd M Hillhouse, Amber L LaCrosse
Current Topics in Behavioral Neurosciences|April 12, 2018
Drug Discrimination: Historical Origins, Important Concepts, and PrinciplesJoseph H Porter, Adam J Prus, Donald A Overton
The Journal of Pharmacology and Experimental Therapeutics|June 4, 2009
Differential effects of M1 and 5-hydroxytryptamine1A receptors on atypical antipsychotic drug-induced dopamine efflux in the medial prefrontal cortexZhu Li, Adam J Prus, Jin Dai, et al.
Pharmacology, Biochemistry, and Behavior|May 30, 2026
Inhibition of compulsive behavior by dextromethorphan on schedule-induced polydipsia in rats: Role of NMDA, sigma-1, and 5-HT receptorsMadeline T Van Fossen, Alexia G Dalton, Adam J Prus
Drug Development Research|March 27, 2014
The discriminative stimulus effects of the neurotensin NTS1 receptor agonist PD149163 in rats: stimulus generalization testing with dopamine D1 and D2 receptor ligandsAdam J Prus, Candice J Schuck, Kristoffer R Rusch, et al.
Behavioural Pharmacology|February 24, 2006
Discriminative stimulus properties of the atypical antipsychotic drug clozapine in rats trained to discriminate 1.25 mg/kg clozapine vs. 5.0 mg/kg clozapine vs. vehicleAdam J Prus, Scott D Philibin, Alan L Pehrson, et al.
Brain Research|November 9, 2007
The neurotensin analog NT69L enhances medial prefrontal cortical dopamine and acetylcholine efflux: potentiation of risperidone-, but not haloperidol-, induced dopamine effluxAdam J Prus, Mei Huang, Zhu Li, et al.
Psychopharmacology|August 19, 2004
Discriminative stimulus properties of the atypical antipsychotic clozapine and the typical antipsychotic chlorpromazine in a three-choice drug discrimination procedure in ratsJoseph H Porter, Adam J Prus, Robert E Vann, et al.
Brain Research|January 17, 2017
Neurotensin NTS<sub>1</sub> and NTS<sub>2</sub> receptor agonists produce anxiolytic-like effects in the 22-kHz ultrasonic vocalization model in ratsFloyd F Steele, Shannon C Whitehouse, Jacob S Aday, et al.
Brain Research|January 9, 2007
5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampusZhu Li, Mei Huang, Adam J Prus, et al.
Pageof 4